Since its founding in 1983 when it brought the first desiccant breather to market, Des-Case has become a leading provider of contamination control products and services for industrial lubricants. Its breathers, custom fluid handling equipment, consulting and educational services help companies around the world improve their equipment reliability, reducing maintenance costs and downtime.
“Des-Case is an industry thought leader and has a unique value proposition that delivers customized products and services to a wide range of industries that are just beginning to understand the benefits of lubricant contamination control,” said Scott Finegan, Managing Director at Pfingsten. “The Des-Case management team has built an outstanding business with an excellent brand name, and we are excited to partner with them to assist with further growth in the rapidly expanding equipment reliability market.” “The new partnership will allow us to embark on our next stage of growth,” said Des-Case President & CEO, Brian Gleason. “Pfingsten’s conservative capital structure and operating capability will provide Des-Case additional resources to further expand our geographic reach both domestically and internationally, customizing our solutions to key end-markets and continuing investment in new product development.”
The transaction was completed on October 31, 2013. The management team retained a significant ownership stake in the company.
For more information on Des-Case, visit www.descase.com
About Pfingsten Pfingsten is an operationally-driven private equity firm focused on long-term value creation. From our headquarters in Chicago, and representative offices in ChangAn, China, and New Delhi, India, we help businesses by applying our operational and global resources to unlock value and propel growth. Since completing our first investment in 1991, Pfingsten raised four funds with total commitments of approximately $1.0 billion, and invested in 92 manufacturing, distribution and business services companies. We are currently investing Pfingsten Fund IV with $525 million of committed capital.
